The Prescribing Clinical Network recommends the use of Atropine for the treatment of painful ciliary spasm in blind eyes

Atropine will be considered to be BLUE (no information sheet) on the traffic light system.

Initiation will be by consultant ophthalmologists and transfer of care can be considered after a minimum of 2 months prescribing by the consultant and once the patient has shown to be benefiting from treatment.

New patients:

·         Should be initiated on Atropine 1% minims® by their consultant ophthalmologist 

·         Patients with manual dexterity issues can be initiated on Atropine 1% eye drop (bottles)

Switching patients from Atropine 1% eye drops:

Patients currently using Atropine 1% eye drops for this indication who do not have manual dexterity issues, should be switched to Atropine 1% minims® at their next medication review.